TD Asset Management »

Eyepoint Pharmaceuticals shares owned by TD Asset Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.3M 143k 23.11
2023-09-30 $574k 72k 7.99

More positions owned by TD Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
NVIDIA Corporation (NVDA)
Canadian Pacific Kansas City (CP)
UnitedHealth (UNH)
Canadian Natl Ry (CNI)
Amazon (AMZN)
Visa Com Cl A (V)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
Eli Lilly & Co. (LLY)

View all positions for TD Asset Management

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Franklin Resources
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Perceptive Advisors
Millennium Management
Ikarian Capital
Deutsche Bank Aktiengesellschaft
Federated Investors
Fiera Capital Corporation
Laurion Capital Management
UBS Group
Goldman Sachs Group
Oracle Investment Management

View all funds holding Eyepoint Pharmaceuticals